Invivyd, Inc. (IVVD)
NASDAQ: IVVD · Real-Time Price · USD
1.200
-0.270 (-18.37%)
May 14, 2026, 12:23 PM EDT - Market open
Invivyd Employees
Invivyd had 122 employees as of December 31, 2025. The number of employees increased by 22 or 22.00% compared to the previous year.
Employees
122
Change (1Y)
22
Growth (1Y)
22.00%
Revenue / Employee
$437,918
Profits / Employee
-$430,238
Market Cap
339.36M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 122 | 22 | 22.00% | 122 | 0 |
| Dec 31, 2024 | 100 | 5 | 5.26% | 99 | 1 |
| Dec 31, 2023 | 95 | 9 | 10.47% | 94 | 1 |
| Dec 31, 2022 | 86 | -17 | -16.50% | 84 | 2 |
| Dec 31, 2021 | 103 | - | - | 101 | 2 |
Related Stocks
| Company Name | Employees |
|---|---|
| Rocket Pharmaceuticals | 202 |
| Enanta Pharmaceuticals | 120 |
| C4 Therapeutics | 104 |
| Verastem | 102 |
| Century Therapeutics | 78 |
| Larimar Therapeutics | 71 |
| PureTech Health | 56 |
| X4 Pharmaceuticals | 45 |
IVVD News
- 3 hours ago - Invivyd Earnings Call Transcript: Q1 2026 - Transcripts
- 5 hours ago - Invivyd Reports First Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 3 days ago - Invivyd and Collaborators Author New Manuscript Evaluating Early Tolerability of COVID Monoclonal Antibody and Comparing Results to COVID Vaccination - GlobeNewsWire
- 7 days ago - Invivyd to Host First Quarter 2026 Financial Results and Corporate Update Call on May 14, 2026 - GlobeNewsWire
- 9 days ago - Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 24 days ago - Invivyd annouces Chairman Elia to speak at POLITICO Health Care Summit - TheFly
- 24 days ago - Invivyd Announces Chairman Marc Elia to Speak at POLITICO Health Care Summit - GlobeNewsWire
- 5 weeks ago - Invivyd provides update on Phase 3 DECLARATION study of VYD2311 - TheFly